lenvatinib,pembrolizumab,ribociclib
merck,eisai,novartis
['keytruda', 'lenvima']
#keytruda plus #lenvima showed no statistical significance versus lenvima monotherapy in #patients with #livercancer. #esmo22 #esmo2022 #onctwitter #cancer #oncology #news #media #medtwitter #news #media #conferences #esmo #globalhealth
iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma